Status:
ACTIVE_NOT_RECRUITING
EndeavorOTC™ Prospective Product Registry
Lead Sponsor:
Akili Interactive Labs, Inc.
Conditions:
ADHD
Eligibility:
All Genders
Brief Summary
The EndeavorOTC product registry aims to collect real world data from EndeavorOTC users. The objectives of this registry are to describe clinical and demographic characteristics, treatment patterns, c...
Detailed Description
All EndeavorOTC users who subscribe to EndeavorOTC are invited to participate in this product registry. Users must provide their informed consent and have an active subscription to the product at time...
Eligibility Criteria
Inclusion
- Has an active EndeavorOTC™subscription
- Provide informed consent to participate in the registry
Exclusion
- N/A
Key Trial Info
Start Date :
October 3 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2026
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT06109051
Start Date
October 3 2023
End Date
December 31 2026
Last Update
June 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akili Interactive Labs, Inc.
Boston, Massachusetts, United States, 02110